Literature DB >> 2837272

Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir).

S A Teich1, J Castle, A H Friedman, W Siroty, J Orellana, M Schmitterer.   

Abstract

The eyes of an AIDS patient with cytomegalovirus (CMV) retinitis and pneumonitis who died while receiving maintenance therapy with the antiviral agent 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir) were obtained for pathological examination. While under treatment the patient had significant improvement but not complete regression of retinitis. Electron microscopic and immunofluorescent techniques revealed cytomegalovirus particles in the retina, sclera, iris, and ciliary body. These findings are consistent with a virostatic type of inhibition of CMV by this agent. They also suggest that CMV involvement in the eye and other organs may be more widespread than is clinically apparent in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837272      PMCID: PMC1041436          DOI: 10.1136/bjo.72.4.293

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  Adult cytomegalovirus inclusion retino-uveitis.

Authors:  L C Chumbley; D M Robertson; T F Smith; R J Campbell
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

2.  BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro.

Authors:  A S Tyms; J M Davis; D J Jeffries; J D Meyers
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

3.  Death in the AIDS patient: role of cytomegalovirus.

Authors:  A M Macher; C M Reichert; S E Straus; D L Longo; J Parrillo; H C Lane; A S Fauci; A H Rook; J F Manischewitz; G V Quinnan
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

4.  Viral particles in the conjunctiva of a patient with the acquired immune deficiency syndrome.

Authors:  S A Teich; S Tay; A H Friedman; M E Schmitterer
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965

5.  Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Authors:  M J Tocci; T J Livelli; H C Perry; C S Crumpacker; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 6.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

7.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

8.  Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.

Authors:  E C Mar; Y C Cheng; E S Huang
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Autopsy findings in the acquired immune deficiency syndrome.

Authors:  K Welch; W Finkbeiner; C E Alpers; W Blumenfeld; R L Davis; E A Smuckler; J H Beckstead
Journal:  JAMA       Date:  1984-09-07       Impact factor: 56.272

10.  Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Authors:  D F Smee; J C Martin; J P Verheyden; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more
  2 in total

1.  Long term therapy of cytomegalovirus retinitis with ganciclovir in a child with acquired immunodeficiency syndrome.

Authors:  S A Halperin; G R La Roche
Journal:  Can J Infect Dis       Date:  1993-01

Review 2.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.